DA 9701

Next Previous
Drug Profile

DA 9701

Alternative Names: DA-9701; Motilitone

Latest Information Update: 15 Dec 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dong-A Pharmaceutical
  • Developer Dong-A Pharmaceutical; Dong-A ST
  • Class Phytotherapies
  • Mechanism of Action Motilin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Dyspepsia

Highest Development Phases

  • Marketed Non-ulcer dyspepsia
  • Clinical Phase Unknown Constipation

Most Recent Events

  • 22 Jan 2016 Preclinical trials in Non-ulcer dyspepsia in China (PO) before January 2016 (Dong-A ST Pipeline, January 2016)
  • 01 Mar 2015 Phase-II clinical trials in Non-ulcer dyspepsia in USA (PO) (NCT02365701)
  • 24 Feb 2015 Dong-A Pharmaceutical plans a phase II trial for Non-ulcer dyspepsia in USA (NCT02365701)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top